Two coagulation tests, Recalcified Activated Clotting Time (RACT) and Hemochron, were compared with the activated partial thromboplastin time (APTT) in in vitro heparinization experiments and in patients heparinized for long term extracorporeal circulation (ECC) to determine their suitability as guidelines for heparin administration. All tests had good precision, with a small variability between methods. There was satisfactory correlation with the heparin level in vivo (r = 0.77 for RACT; r = 0.80 for Hemochron and r = 0.82 for APTT) too, while the in vitro r was always greater than or equal to 0.94. Nevertheless, APTT values for plasma heparin levels higher than 1.5 U/ml were markedly prolonged, with a large standard deviation, and often "...
This study compares four different activated clotting time (ACT) point-of-care (POC) testing systems...
Postoperative bleeding is a common complication after cardiac surgery applying cardiopulmonary bypas...
The Hemochron® Response is a third generation point-of-care (POC) whole blood coagulation analyzer t...
A b s t r a c t The objectives of the present study were to evaluate the relationship between hepari...
Whole blood coagulation analysers are widely used during percutaneous coronary interventions. The pr...
<div><div><div><p>Heparin is frequently used in different clinical settings to reduce the coagulatin...
A critical review is given of the tests available for the assessment of the action of anticoagulants...
The automated-activated coagulation time, manual-activated coagulation tim e and the activated parti...
Heparin is an effective drug for prevention and treatment of thromboembolic conditions. Although sev...
Abstract. Three automated spectrophotometric heparin assays were inyestigated. The day-to-day reprod...
Activated Clotting Time (ACT) has been the standard for monitoring heparin anticoagulation in cardia...
At present, we are using the proposed therapeutic range for monitoring unfractionated heparin therap...
ment Test (LHMT), a method for point-of-care testing (POCT) of heparinization, has been designed to ...
Heparin can be quantified with antifactor Xa and IIa tests (aXa, aIIa) but the anticoagulant power o...
INTRODUCTION: Patients on intravenous heparin require regular activated partial thromboplastin time ...
This study compares four different activated clotting time (ACT) point-of-care (POC) testing systems...
Postoperative bleeding is a common complication after cardiac surgery applying cardiopulmonary bypas...
The Hemochron® Response is a third generation point-of-care (POC) whole blood coagulation analyzer t...
A b s t r a c t The objectives of the present study were to evaluate the relationship between hepari...
Whole blood coagulation analysers are widely used during percutaneous coronary interventions. The pr...
<div><div><div><p>Heparin is frequently used in different clinical settings to reduce the coagulatin...
A critical review is given of the tests available for the assessment of the action of anticoagulants...
The automated-activated coagulation time, manual-activated coagulation tim e and the activated parti...
Heparin is an effective drug for prevention and treatment of thromboembolic conditions. Although sev...
Abstract. Three automated spectrophotometric heparin assays were inyestigated. The day-to-day reprod...
Activated Clotting Time (ACT) has been the standard for monitoring heparin anticoagulation in cardia...
At present, we are using the proposed therapeutic range for monitoring unfractionated heparin therap...
ment Test (LHMT), a method for point-of-care testing (POCT) of heparinization, has been designed to ...
Heparin can be quantified with antifactor Xa and IIa tests (aXa, aIIa) but the anticoagulant power o...
INTRODUCTION: Patients on intravenous heparin require regular activated partial thromboplastin time ...
This study compares four different activated clotting time (ACT) point-of-care (POC) testing systems...
Postoperative bleeding is a common complication after cardiac surgery applying cardiopulmonary bypas...
The Hemochron® Response is a third generation point-of-care (POC) whole blood coagulation analyzer t...